Clinical trials recruiting for Castration-Resistant Prostate Carcinoma
13
Recruiting trials
40
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 7 |
| Washington | 4 |
| Illinois | 3 |
| Michigan | 3 |
| Montana | 3 |
| Texas | 3 |
| Wisconsin | 3 |
| Delaware | 2 |
| Florida | 2 |
| Idaho | 2 |
| Iowa | 2 |
| Maryland | 2 |
Top cities
Seattle, Washington 4Ann Arbor, Michigan 2Billings, Montana 2Bloomington, Illinois 2Bozeman, Montana 2Brighton, Michigan 2Canton, Illinois 2Canton, Michigan 2Chelsea, Michigan 2Chicago, Illinois 2
Self-screener
Recruiting trials
- Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
- Imaging of Solid Tumors Using 18F-TRX
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
- Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
- Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Related conditions
Trials recruiting for Castration-Resistant Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Stage IVB Prostate Cancer AJCC v8 27Prostate cancer 1234Metastatic Prostate Adenocarcinoma 13Stage IVA Prostate Cancer AJCC v8 13Metastatic Prostate Carcinoma 13Stage IV Prostate Cancer AJCC v8 14Stage IV Renal Cell Cancer AJCC v8 9Metastatic Malignant Solid Neoplasm 21Metastatic Malignant Neoplasm in the Bone 3Stage IVC Colorectal Cancer AJCC v8 7
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Castration-Resistant Prostate Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.